2021-09-16
Thur
08:00-09:40
Online
Young Investigator Award (1)
08:00-08:10
Assessment of hepatic steatosis in metabolic dysfunction-associated fatty liver disease by using attenuation imaging
Assessment of hepatic steatosis in metabolic dysfunction-associated fatty liver disease by using attenuation imaging
08:10-08:20
Contrast-enhanced US with sonazoid for the diagnosis of focal liver lesions ：a multicentre prospective study
Contrast-enhanced US with sonazoid for the diagnosis of focal liver lesions: a multicentre prospective study
08:20-08:30
Ultrasound guided percutaneous microwave ablation of inoperable breast cancer with the skin and/or nipple areola complex involvement
Ultrasound guided percutaneous microwave ablation of inoperable breast cancer with the skin and/or nipple areola complex involvement
08:30-08:40
Diagnosis of hepatic steatosis using an ultrasonic quantitative index based on time-frequency entropy
Diagnosis of hepatic steatosis using an ultrasonic quantitative index based on time-frequency entropy
08:40-08:50
Hepatic steatosis grading by using grad-CAM-based ultrasound weighted entropy estimation
Hepatic steatosis grading by using grad-CAM-based ultrasound weighted entropy estimation
08:50-09:00
Efficacy of ultrasound attenuation imaging and fibroscan© controlled attenuation parameter in non-alcoholic fatty liver disease patients
Efficacy of ultrasound attenuation imaging and fibroscan© controlled attenuation parameter in non-alcoholic fatty liver disease patients
09:00-09:10
Anti-tumor effect of cRGD-PEG-PLGA drug and gene loaded nanoparticles combined with UTD on breast cancer in vitro
Anti-tumor effect of cRGD-PEG-PLGA drug and gene loaded nanoparticles combined with UTD on breast cancer in vitro
09:10-09:20
Theranostic nanomedicine carrying l-menthol and near-infrared dye ir-780 for multimodal imaging-guided photothermal therapy of cancer
Theranostic nanomedicine carrying l-menthol and near-infrared dye ir-780 for multimodal imaging-guided photothermal therapy of cancer
